Audiology

Medicine & Life Sciences

1. Angiopoietin-2 10%
2. Anterior Uveitis 9%
3. Aptitude 11%
4. Attentional Blink 11%
5. Audiologists 45%
6. Audiology 32%
7. Auditory Perceptual Disorders 12%
8. Biomarkers 11%
9. Blindness 14%
10. Cataract 13%
11. Child 13%
12. Chlorocebus aethiops 10%
13. Choroidal Neovascularization 26%
14. Cochlea 14%
15. Cochlear Implants 16%
16. Cochlear Nerve 25%
17. Cohort Studies 11%
18. Color 22%
19. Communication 10%
20. Cues 15%
21. Cultural Anthropology 10%
22. Dark Adaptation 10%
23. Decision Making 10%
24. Decision Support Techniques 20%
25. Degenerative Myopia 11%
26. Diabetic Retinopathy 72%
27. Dilatation 13%
28. Dye Lasers 10%
29. Elderly 24%
30. Electroencephalography 14%
31. England 15%
32. Eucalyptol 11%
33. Eye 66%
34. Eye Diseases 23%
35. Glaucoma 14%
36. Grounded Theory 11%
37. Hearing 45%
38. Hearing Loss 38%
39. Hemoglobins 10%
40. Hemorheology 11%
41. Hemorrhage 16%
42. Hyperacusis 10%
43. Interviews 13%
44. Intravitreal Injections 11%
45. Joint Prosthesis 10%
46. King Denborough syndrome 29%
47. Lasers 30%
48. Light Coagulation 30%
49. lipoteichoic acid 10%
50. Longitudinal Studies 19%
51. Macular Degeneration 100%
52. Macular Edema 36%
53. Macular Pigment 15%
54. Microaneurysm 16%
55. National Health Programs 10%
56. Nerve Fibers 13%
57. Noise 33%
58. Noise-Induced Hearing Loss 9%
59. Ocular Vision 13%
60. Ophthalmologists 14%
61. Ophthalmology 17%
62. Ophthalmoscopy 13%
63. Optic Disk 45%
64. Optical Coherence Tomography 52%
65. Optometrists 14%
66. Parents 15%
67. Parkinson Disease 18%
68. Pediatrics 10%
69. Photochemotherapy 23%
70. Photography 15%
71. Population 23%
72. Prospective Studies 14%
73. Psychological Inhibition 12%
74. Psychology 10%
75. Pure-Tone Audiometry 11%
76. Ranibizumab 31%
77. Referral and Consultation 17%
78. Retina 18%
79. Retinal Arterial Macroaneurysm 21%
80. Retinal Artery 15%
81. Retinal Drusen 28%
82. Retinal Vessels 12%
83. Seizures 11%
84. Shared Decision Making 10%
85. Social Isolation 10%
86. Systematic Reviews 22%
87. Therapeutics 17%
88. TIE-2 Receptor 11%
89. Tin 10%
90. Tinnitus 75%
91. Unilateral Hearing Loss 10%
92. Vascular Endothelial Growth Factor A 15%
93. Verteporfin 26%
94. Vision Disorders 10%
95. Visual Acuity 29%
96. Visual Field Tests 22%
97. Visual Fields 33%
98. Vitreous Hemorrhage 13%
99. Whistleblowing 13%
100. White Dot Syndromes 11%